MARKET EOD
NIFTY 50:23,960.60▲ +149.75 (+0.63%)
SENSEX:77,301.40▲ +886.41 (+1.16%)
BANK NIFTY:55,913.60▲ +373.55 (+0.67%)
NIFTY IT:32,061.90▼ -489.70 (-1.50%)
MCX GOLD:₹139,452.00▼ -734.00 (-0.52%)
MCX SILVER:₹179,698.00▼ -4,081.00 (-2.22%)
MCX CRUDEOIL:₹9,104.00▲ +32.00 (+0.35%)
USD/INR:₹94.8343▼ -0.9382 (-0.98%)
YT X
Advertisement • SRK Money Talk
Home › Company Intelligence › GKB Ophthalmics Limited (GKB)
NSE: GKB MID_CAP Diversified REPORTED STATUTORY SOURCE • Data as of FY26 FRESH

GKB Ophthalmics Limited

Units: ₹ Crores • Basis: Standalone • Reporting Period: FY26 • Source: BSE_OFFICIAL_ANNUAL_STANDALONE • Last Checked: 17 Sep 2026
FY26 Revenue ₹25.64 Cr
FY26 Net Profit ₹-3.57 Cr
Reported EPS ₹-7.08
Operating Margin 4.73%
Return on Equity N/A
ROCE N/A
Debt / Equity N/A
Net Profit Margin -13.91%
WHAT IS HAPPENING NOW • MATERIAL DEVELOPMENTS

Latest Earnings Released (Q1 FY27): Reported quarterly statutory revenue of ₹6.40 Cr with net profit of ₹-0.50 Cr (EPS: ₹-1.00).

Exchange Disclosure (2026-08-26): Shareholder Meeting / Postal Ballot-Scrutinizer''s Report — The 44th Annual General Meeting of the Company was held on August 25, 2026 at 11:00 A.M. ,at the registered office of the Company at 16-A, Tivim Industrial Estate, Mapusa Goa-403526. Pursuant to Regulation 44 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the following: 1. Consolidated Voting Results pursuant to Regulation 44(3) of SEBI Listing Regulations as Annexure I 2. Scrutinizers'' Report pursuant to Section 108 of the Companies Acts 2013 as Annexure II. All Resolutions were passed with requisite majority . Kindly take the same on record.

BUSINESS OVERVIEW & CORPORATE PROFILE

Official listing profile for GKB Ophthalmics Limited under Diversified.

Official listing profile for GKB Ophthalmics Limited under Diversified.

Key Offerings & Operating Lines:

Commercial & Industrial

Headquarters India
Incorporated N/A
Workforce N/A
Statutory Auditor N/A
Credit Rating N/A
SRK FUNDAMENTAL HEALTH SCORE Under Review / Insufficient Data

Score Under Review

Fundamental Health Score calculation requires a minimum of two consecutive audited annual financial filings. This corporation profile is currently awaiting complete verified financial history before generating an algorithmic score.

Advertisement • SRK Money Talk
FINANCIAL PERFORMANCE • STATEMENT OF PROFIT & LOSS (IND-AS) Ind-AS • REPORTED EXCHANGE DATA
Multi-Year Revenue & Net Profit Trajectory (₹ Crores • Ind-AS)
₹0k₹0k₹0k₹0k₹0kRevenue: ₹27 CrNet Profit: ₹-2 CrFY22Revenue: ₹28 CrNet Profit: ₹-3 CrFY23Revenue: ₹31 CrNet Profit: ₹-3 CrFY24Revenue: ₹33 CrNet Profit: ₹-6 CrFY25Revenue: ₹26 CrNet Profit: ₹-4 CrFY26RevenueNet Profit
Annual Financial Statements (₹ Crores • Ind-AS Normalized) Latest Period End: 31 Mar 2026 • Source: BSE_OFFICIAL_ANNUAL_STANDALONE
Annual Metric (₹ Cr)FY22
Mar 2022
FY23
Mar 2023
FY24
Mar 2024
FY25
Mar 2025
FY26
Mar 2026
Sales / Revenue from Operations₹27₹28₹31₹33₹26
Operating Expenditure₹29₹30₹34₹38₹33
Operating Profit (EBITDA)₹-1.78₹-2.59₹-2.87₹-5.37₹-6.93
Operating Profit Margin (OPM %)5.60%3.59%2.58%-4.60%4.73%
Other Income₹1.96₹2.09₹2.08₹1.97₹5.97
Finance Costs / Interest₹1.34₹1.50₹1.59₹1.89₹2.17
Depreciation & Amortization₹2.49₹2.54₹2.59₹2.64₹2.69
Profit Before Tax (PBT)₹-2.31₹-3.04₹-3.38₹-6.04₹-3.65
Tax Expense₹0₹0.16₹-0.04₹-0.07₹0.08
Net Profit (PAT)₹-2.31₹-2.88₹-3.42₹-6.11₹-3.57
Net Profit Margin (NPM %)-8.54%-10.39%-10.96%-18.65%-13.91%
Basic / Diluted EPS (₹)₹-4.58₹-5.72₹-6.78₹-12.12₹-7.08
Recent Quarterly Performance (₹ Crores • SEBI LODR Reg 33)Latest Quarter End: 30 Jun 2026 • Source: BSE_OFFICIAL_REPORT_STANDALONE
Quarterly Metric (₹ Cr)Q4 FY14
Mar 2014
Q1 FY15
Jun 2014
Q2 FY15
Sep 2014
Q1 FY26
Jun 2025
Q2 FY26
Sep 2025
Q3 FY26
Dec 2025
Q4 FY26
Mar 2026
Q1 FY27
Jun 2026
Sales / RevenueN/AN/AN/A₹8.78₹6.11₹4.36₹6.40₹6.40
Operating Profit (EBITDA)₹1.39₹-0.44₹-1.61₹-1.52₹-1.19₹-1.95₹-2.26₹-0.55
OPM %N/AN/AN/A-8.80%12.20%50.19%-14.79%3.41%
Profit Before Tax (PBT)₹1.39₹-0.44₹-1.61₹-2.13₹-0.51₹0.91₹-1.93₹-0.74
Net Profit (PAT)₹-0.28₹-0.44₹-1.48₹-2.14₹-0.52₹0.98₹-1.88₹-0.50
NPM %N/AN/AN/A-24.42%-8.57%22.49%-29.41%-7.84%
Basic / Diluted EPS (₹)₹-0.68₹-1.06₹-3.55₹-4.25₹-1.04₹1.95₹-3.74₹-1.00
BALANCE SHEET & CASH FLOW INTELLIGENCE (₹ CRORES • AUDITED) Exchange Reported
Annual Balance Sheet Strength (₹ Crores • Schedule III Ind-AS)
Balance Sheet Item (₹ Cr)FY22FY23FY24FY25FY26
Equity Share Capital₹5.04₹5.04₹5.04₹5.04₹5.04
Reserves & SurplusN/AN/AN/AN/AN/A
Net Worth (Shareholders' Funds)N/AN/AN/AN/AN/A
Total Borrowings & DebtN/AN/AN/AN/AN/A
Total Balance Sheet AssetsN/AN/AN/AN/AN/A
Cash Flow Statement (₹ Crores • Indirect Method)
Cash Flow Item (₹ Cr)FY22FY23FY24FY25FY26
Cash Flow from Operating Activities (CFO)N/AN/AN/AN/AN/A
Cash Flow from Investing Activities (CFI)N/AN/AN/AN/AN/A
Cash Flow from Financing Activities (CFF)N/AN/AN/AN/AN/A
Free Cash Flow / Net Cash FlowN/AN/AN/AN/AN/A
PROFITABILITY, RETURN & SOLVENCY RATIOS Derived from Verified Filings
Financial Ratio / Efficiency MetricFY22FY23FY24FY25FY26
Operating Profit Margin (OPM)5.60%3.59%2.58%-4.60%4.73%
Net Profit Margin (NPM)-8.54%-10.39%-10.96%-18.65%-13.91%
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Capital Employed (ROCE)N/AN/AN/AN/AN/A
Debt to Equity RatioN/AN/AN/AN/AN/A
Interest Coverage Ratio-1.3x-1.7x-1.8x-2.8x-3.2x
SHAREHOLDING INTELLIGENCE • INSTITUTIONAL FLOWS SEBI LODR Reg 31
HOLDING PATTERN
Promoter: 51.15%
FII: 0.00%
DII: 0.00%
Public: 48.85%
Pledged: 0.00%
Quarterly Shareholding Trend & Institutional Inflows
CategoryJun 2026Mar 2026Dec 2025QoQ Shift
Promoter Holding51.15%51.13%51.13%+0.02%
Foreign Institutional (FII)0.00%0.00%0.00%0.00%
Domestic Institutional (DII / MFs)0.00%0.00%0.00%0.00%
Public & Retail48.85%48.87%48.87%-0.02%
Promoter Pledged Shares0.00%0.00%0.00%—
KEY MANAGEMENT & BOARD GOVERNANCE
Management data not yet available for this entity
Statutory disclosures regarding Key Managerial Personnel (KMP) and Board of Directors will appear here once verified from official exchange filings.
CORPORATE ACTIONS & DIVIDEND TRACK RECORD
Latest Dividend Paid ₹2.00
LTM Total Dividend ₹44.35
Dividends Recorded 10 payouts
Corporate Action Disclosures (Dividends, Bonus & Splits)
TypeEx-DateRecord DateAmount / RatioDescription
DIVIDEND2026-09-152026-09-15₹2.00Final Dividend - Rs. - 2.0000
DIVIDEND2026-09-152026-09-15₹7.00Final Dividend - Rs. - 7.0000
DIVIDEND2026-09-152026-09-15₹0.50Final Dividend - Rs. - 0.5000
DIVIDEND2026-09-152026-09-15₹5.00Final Dividend - Rs. - 5.0000
DIVIDEND2026-09-152026-09-15₹0.55Final Dividend - Rs. - 0.5500
DIVIDEND2026-09-152026-09-15₹25.00Final Dividend - Rs. - 25.0000
DIVIDEND2026-09-152026-09-15₹3.00Final Dividend - Rs. - 3.0000
CORPORATE_ACTION2026-09-152026-09-15N/ARight Issue of Equity Shares
DIVIDEND2026-09-152026-09-15₹1.00Final Dividend - Rs. - 1.0000
DIVIDEND2026-09-152026-09-15₹0.30Final Dividend - Rs. - 0.3000
CORPORATE_ACTION2014-08-26N/AN/AAnnual General Meeting
CORPORATE_ACTION2013-08-21N/AN/AAnnual General Meeting
CORPORATE_ACTION2012-08-02N/AN/A30th Annual General Meeting
CORPORATE_ACTION2011-09-21N/AN/AAnnual General Meeting
DIVIDEND2010-09-21N/A₹1.20Annual General Meeting And Dividend Of Rs.1.20 Per Share
REGULATORY FILINGS & EXCHANGE DISCLOSURES
AGM/EGM 26 Aug 2026, 02:30 PM • BSE_OFFICIAL_API
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

The 44th Annual General Meeting of the Company was held on August 25, 2026 at 11:00 A.M. ,at the registered office of the Company at 16-A, Tivim Industrial Estate, Mapusa Goa-403526. Pursuant to Regulation 44 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the following: 1. Consolidated Voting Results pursuant to Regulation 44(3) of SEBI Listing Regulations as Annexure I 2. Scrutinizers'' Report pursuant to Section 108 of the Companies Acts 2013 as Annexure II. All Resolutions were passed with requisite majority . Kindly take the same on record.

AGM/EGM 25 Aug 2026, 12:50 PM • BSE_OFFICIAL_API
Shareholder Meeting / Postal Ballot-Outcome of AGM

The 44th Annual General Meeting of the Company was held today i.e Tuesday , August 25th, 2026, at 11.00 A. M., at the Registered Office of the Company at 16- A, Tivim Industrial Estate, Mapusa- Goa, 403526. The proceedings of the AGM are enclosed herewith. The meeting started at 11. A.M and ended at 11. 25 A.M. Kindly take the same on record.

Company Update 14 Aug 2026, 12:22 PM • BSE_OFFICIAL_API
Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, published in Business standard (English Edition) and on Pudhari ( Marathi) dated August 14, 2026. Please acknowledge the receipt.

Result 12 Aug 2026, 06:35 PM • BSE_OFFICIAL_API
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026.

Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The above unaudited Financial Results and the Limited Review Reports are available on the Company''s website at www.gkb.net and on the BSE website www.bseindia.com

Board Meeting 12 Aug 2026, 06:11 PM • BSE_OFFICIAL_API
Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Ltd., Held On August 12, 2026

The meeting of the Board of Directors of the Company was held on August 12, 2026 which considered and took on record inter alia the unaudited Standalone and Consolidated Financial Results of the Companty for the quarter ended June 30, 2026. The above unaudited Fiancial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and the BSE website www.bseindia.com. The Board of Directors'' Meeting started at 4:35 P.M. (IST) and ended at 5:30 P.M.(IST) on the same day. Kindly take the information on record.

Company Update 01 Aug 2026, 12:23 PM • BSE_OFFICIAL_API
Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached copies of newspaper cuttings of the Notice published in The Times of India (Goa Edition) dated August 01, 2026, Pudhari (Marathi) dated August 01, 2026, and Business Standard (English Edition) dated August 01, 2026, with respect to the completion of dispatch of Notice of Annual General Meeting together with Annual Report for the Financial year 2025-26. Please acknowledge receipt

Company Update 31 Jul 2026, 04:25 PM • BSE_OFFICIAL_API
Disclosure Of Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015("Listing Regulations'')

Pursuant to Regulation 36(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Company has sent a letter to those shareholders whose email addresses are not registered with Company/ RTA/ Depository Participant, providing a web- link of Company''s website from where the Annual Report for F.Y. 2025-26 can be accessed. The specimen of the letter is enclosed for your reference and records the same is uploaded on the website of the Company. Kindly take the information on record.

Corp. Action 31 Jul 2026, 01:04 PM • BSE_OFFICIAL_API
Notice For Book Closure

Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act 2013, read with Rule 10 of Companies (Management and Administration)Rules 2014, we would like to inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday August 19, 2026 to Tuesday August 25, 2026 (both days inclusive) for the purpose of the 44th Annual General Meeting of the Company to be held on Tuesday, August 25, 2026. No Dividend is proposed for the Year 2025-26. Kindly take the same on record.

UNIFIED CORPORATE CHRONOLOGICAL TIMELINE
2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 2.0000

Final Dividend - Rs. - 2.0000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 7.0000

Final Dividend - Rs. - 7.0000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 0.5000

Final Dividend - Rs. - 0.5000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 5.0000

Final Dividend - Rs. - 5.0000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 0.5500

Final Dividend - Rs. - 0.5500

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 25.0000

Final Dividend - Rs. - 25.0000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 3.0000

Final Dividend - Rs. - 3.0000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Right Issue of Equity Shares

Right Issue of Equity Shares

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 1.0000

Final Dividend - Rs. - 1.0000

2026-09-15 CORPORATE_ACTION • SRK Intelligence
GKB Ophthalmics Limited: Final Dividend - Rs. - 0.3000

Final Dividend - Rs. - 0.3000

2026-09-15 DIVIDEND • BSE_OFFICIAL_API
Dividend: ₹2.00 per share

Final Dividend - Rs. - 2.0000

2026-09-15 DIVIDEND • BSE_OFFICIAL_API
Dividend: ₹7.00 per share

Final Dividend - Rs. - 7.0000

STATUTORY SOURCE PROVENANCE & VERIFICATION AUDIT TRAIL
BSE Official Filings (533212) ↗ NSE Official Quote (GKB) ↗

Every financial metric, balance-sheet balance, and shareholding breakdown displayed on this dossier is grounded in primary statutory filings submitted to Indian stock exchanges (SEBI LODR Regulations 31, 33, and 47). No data is manufactured, estimated, or interpolated.

Data Domain Reporting Period Statutory Source Ingestion Date Status Provenance Hash
financials_quarterly Q2 FY15 NSE_OFFICIAL_API 03 Nov 2026, 19:17 VERIFIED 486505d5b014...
financials_quarterly Q2 FY15 NSE_OFFICIAL_API 31 Oct 2026, 19:47 VERIFIED b07c43580add...
financials_quarterly Q2 FY15 NSE_OFFICIAL_API 28 Oct 2026, 14:45 VERIFIED 486505d5b014...
financials_quarterly Q2 FY15 NSE_OFFICIAL_API 26 Oct 2026, 01:47 VERIFIED 486505d5b014...
financials_quarterly Q2 FY15 NSE_OFFICIAL_API 22 Oct 2026, 11:45 VERIFIED 486505d5b014...
financials_quarterly Q2 FY15 NSE_OFFICIAL_API 17 Oct 2026, 20:45 VERIFIED 486505d5b014...
financials_quarterly SCHEDULED_CHECK NSE_OFFICIAL_API 13 Oct 2026, 11:46 VERIFIED b07c43580add...

DATA SOURCES, STATUTORY DISCLOSURES & METHODOLOGY

All corporate identifiers, listed equity data, shareholding patterns, and financial statements are extracted from official regulatory authorities: National Stock Exchange of India (NSE), BSE Limited, and Ministry of Corporate Affairs (MCA) via audited XBRL Ind-AS submissions under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulations 31, 33, and 47). Data is ingested and archived on official end-of-day (EOD) schedules with immutable provenance tracking.

Zero-Fabrication Policy: SRK Money Talk strictly enforces authentic data integrity. No financial values, debt levels, cash flows, or quarterly earnings are ever mathematically synthesized, interpolated, or fabricated. When statutory disclosures have not yet been filed or ingested, fields are strictly labeled as N/A or NOT_YET_AVAILABLE.

Statutory Disclaimer: The SRK Fundamental Health Score is a quantitative diagnostic algorithm based exclusively on historical audited filings and does not constitute an investment recommendation or financial advisory. Always consult a SEBI-registered investment adviser before making capital allocation decisions.